Susquehanna International Group, LLP Sab Biotherapeutics Inc Wt Exp Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 26,302 shares of SABSW stock, worth $789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,302Holding current value
$789% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding SABSW
# of Institutions
11Shares Held
928KCall Options Held
62.5KPut Options Held
0-
Lmr Partners LLP London, X0540KShares$16,1870.0% of portfolio
-
Morgan Stanley New York, NY146KShares$4,3930.0% of portfolio
-
Clear Street Group Inc. New York, NY79KShares$2,3700.0% of portfolio
-
Clear Street LLC78.8KShares$2,3640.0% of portfolio
-
Ubs Group Ag23.4KShares$7020.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology